Cambridge, United Kingdom

Gary Trewartha



 

Average Co-Inventor Count = 7.4

ph-index = 5

Forward Citations = 72(Granted Patents)


Location History:

  • Herts, GB (2008)
  • Stevenage, GB (2011 - 2014)
  • Cambridge, GB (2010 - 2015)

Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Gary Trewartha

Introduction

Gary Trewartha, a prolific inventor based in Cambridge, GB, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 11 patents, Trewartha's work primarily focuses on innovative compounds that could potentially transform cancer treatment.

Latest Patents

Among his latest patents, Gary has developed 3,4-disubstituted 1H-pyrazole compounds, which serve as modulators for cyclin-dependent kinase (CDK) and glycogen synthase kinase-3 (GSK-3). These compounds are pivotal for the prophylaxis or treatment of diseases mediated by CDK and GSK-3, targeting cancerous conditions. The invention details a formula (0) comprising pyrazole compounds that effectively modulate the activity of CDK, GSK, and Aurora kinases. Additionally, Trewartha has delineated pharmaceutical compositions containing these compounds, their manufacturing processes, and their therapeutic applications.

Career Highlights

Gary Trewartha has had an impactful career, notably contributing to renowned organizations such as Astex Therapeutics Limited and the Institute of Cancer Research: Royal Cancer Hospital. His work in these institutions has allowed him to push the boundaries of medicinal chemistry and cancer research.

Collaborations

Throughout his career, Trewartha has collaborated with esteemed colleagues such as Paul Graham Wyatt and Valerio Berdini. These partnerships have not only enriched his research but also facilitated the development of groundbreaking therapeutic avenues.

Conclusion

In summary, Gary Trewartha stands out as an inventive force within the pharmaceutical landscape. With his array of patents focused on crucial cancer treatments, he continues to pave the way for innovations that hold the potential to benefit patients worldwide. The ongoing exploration and development of his compounds reflect a steadfast commitment to improving healthcare outcomes for those affected by severe diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…